GEODE CAPITAL MANAGEMENT, LLC

Holdings History for Cullinan Therapeutics, Inc. - Common Stock, par value $0.0001 per share (CGEM)

Symbol: CGEM on Nasdaq
Investment type: Equity / Common Stock, par value $0.0001 per share

Shares, Excluding Options vs Price

Value, Excluding Options

Holdings date	Weight	Change	Value $	Shares	Change	Activity %	Price	All Holders
31 Dec 2025	0%	+0%	$13,481,334	1,302,262	+6,942	+0.54%	$10.35	Q4 2025
30 Sep 2025	0%	+0%	$7,682,565	1,295,320	+15,824	+1.2%	$5.93	Q3 2025
30 Jun 2025	0%	+0%	$9,636,131	1,279,496	+37,679	+3%	$7.53	Q2 2025
31 Mar 2025	0%	+0%	$9,402,621	1,241,817	+27,176		$7.57	Q1 2025
31 Dec 2024	0%	+0%	$14,797,641	1,214,641	+6,220	+0.51%	$12.18	Q4 2024
30 Sep 2024	0%	+0%	$20,232,636	1,208,421	+231,935	+24%	$16.74	Q3 2024
30 Jun 2024	0%	+0%	$17,033,908	976,486	+299,156	+44%	$17.44	Q2 2024
31 Mar 2024	0%	+0%	$11,543,654	677,330	+21,666	+3.3%	$17.04	Q1 2024
31 Dec 2023	0%	+0%	$6,682,030	655,664	+64,841	+11%	$10.19	Q4 2023
30 Sep 2023	0%	+0%	$5,347,745	590,823	+78,477	+15%	$9.05	Q3 2023
30 Jun 2023	0%	-0%	$5,512,842	512,346	-25,477	-4.7%	$10.76	Q2 2023
31 Mar 2023	0%	-0%	$5,501,929	537,823	-19,285	-3.5%	$10.23	Q1 2023
31 Dec 2022	0%	+0%	$5,877,000	557,108	+15,588	+2.9%	$10.55	Q4 2022
30 Sep 2022	0%	+0%	$6,942,000	541,520	+36,526	+7.2%	$12.82	Q3 2022
30 Jun 2022	0%	+0%	$6,474,000	504,994	+62,453	+14%	$12.82	Q2 2022
31 Mar 2022	0%	+0%	$4,633,000	442,541	+10,670	+2.5%	$10.47	Q1 2022
31 Dec 2021	0%	+0%	$6,663,000	431,871	+10,633	+2.5%	$15.43	Q4 2021
30 Sep 2021	0%	+0%	$9,507,000	421,238	+188,316	+81%	$22.57	Q3 2021
30 Jun 2021	0%	+0%	$5,997,000	232,922	+12,655	+5.7%	$25.75	Q2 2021
31 Mar 2021	0%	+0%	$9,178,000	220,267	+220,267	NEW	$41.67	Q1 2021

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.